Zinc in PDB 5sed: Crystal Structure of Human Phosphodiesterase 10 in Complex with 4-[6- Chloro-2-[(1-Methyl-4-Phenylimidazol-2-Yl)Methoxy]Quinazolin-4- Yl]Morpholine
Enzymatic activity of Crystal Structure of Human Phosphodiesterase 10 in Complex with 4-[6- Chloro-2-[(1-Methyl-4-Phenylimidazol-2-Yl)Methoxy]Quinazolin-4- Yl]Morpholine
All present enzymatic activity of Crystal Structure of Human Phosphodiesterase 10 in Complex with 4-[6- Chloro-2-[(1-Methyl-4-Phenylimidazol-2-Yl)Methoxy]Quinazolin-4- Yl]Morpholine:
3.1.4.17;
Protein crystallography data
The structure of Crystal Structure of Human Phosphodiesterase 10 in Complex with 4-[6- Chloro-2-[(1-Methyl-4-Phenylimidazol-2-Yl)Methoxy]Quinazolin-4- Yl]Morpholine, PDB code: 5sed
was solved by
C.Joseph,
K.Groebke-Zbinden,
J.Benz,
D.Schlatter,
M.G.Rudolph,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
43.49 /
2.32
|
Space group
|
H 3
|
Cell size a, b, c (Å), α, β, γ (°)
|
135.193,
135.193,
235.868,
90,
90,
120
|
R / Rfree (%)
|
19.2 /
24.2
|
Other elements in 5sed:
The structure of Crystal Structure of Human Phosphodiesterase 10 in Complex with 4-[6- Chloro-2-[(1-Methyl-4-Phenylimidazol-2-Yl)Methoxy]Quinazolin-4- Yl]Morpholine also contains other interesting chemical elements:
Zinc Binding Sites:
The binding sites of Zinc atom in the Crystal Structure of Human Phosphodiesterase 10 in Complex with 4-[6- Chloro-2-[(1-Methyl-4-Phenylimidazol-2-Yl)Methoxy]Quinazolin-4- Yl]Morpholine
(pdb code 5sed). This binding sites where shown within
5.0 Angstroms radius around Zinc atom.
In total 4 binding sites of Zinc where determined in the
Crystal Structure of Human Phosphodiesterase 10 in Complex with 4-[6- Chloro-2-[(1-Methyl-4-Phenylimidazol-2-Yl)Methoxy]Quinazolin-4- Yl]Morpholine, PDB code: 5sed:
Jump to Zinc binding site number:
1;
2;
3;
4;
Zinc binding site 1 out
of 4 in 5sed
Go back to
Zinc Binding Sites List in 5sed
Zinc binding site 1 out
of 4 in the Crystal Structure of Human Phosphodiesterase 10 in Complex with 4-[6- Chloro-2-[(1-Methyl-4-Phenylimidazol-2-Yl)Methoxy]Quinazolin-4- Yl]Morpholine
 Mono view
 Stereo pair view
|
A full contact list of Zinc with other atoms in the Zn binding
site number 1 of Crystal Structure of Human Phosphodiesterase 10 in Complex with 4-[6- Chloro-2-[(1-Methyl-4-Phenylimidazol-2-Yl)Methoxy]Quinazolin-4- Yl]Morpholine within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Zn801
b:31.2
occ:1.00
|
OD2
|
A:ASP564
|
1.9
|
25.3
|
1.0
|
NE2
|
A:HIS529
|
2.1
|
35.8
|
1.0
|
NE2
|
A:HIS563
|
2.1
|
25.0
|
1.0
|
O
|
A:HOH934
|
2.2
|
20.7
|
1.0
|
OD1
|
A:ASP674
|
2.2
|
30.8
|
1.0
|
O
|
A:HOH946
|
2.6
|
36.3
|
1.0
|
CD2
|
A:HIS563
|
3.0
|
25.8
|
1.0
|
CG
|
A:ASP564
|
3.0
|
25.4
|
1.0
|
CE1
|
A:HIS529
|
3.1
|
32.1
|
1.0
|
CG
|
A:ASP674
|
3.1
|
31.8
|
1.0
|
CD2
|
A:HIS529
|
3.1
|
32.0
|
1.0
|
CE1
|
A:HIS563
|
3.2
|
26.9
|
1.0
|
OD2
|
A:ASP674
|
3.3
|
40.9
|
1.0
|
OD1
|
A:ASP564
|
3.6
|
23.4
|
1.0
|
MG
|
A:MG802
|
3.8
|
24.6
|
1.0
|
O
|
A:HOH965
|
4.1
|
20.6
|
1.0
|
CG
|
A:HIS563
|
4.2
|
25.6
|
1.0
|
ND1
|
A:HIS529
|
4.2
|
32.4
|
1.0
|
CB
|
A:ASP564
|
4.2
|
25.9
|
1.0
|
CD2
|
A:HIS525
|
4.2
|
29.7
|
1.0
|
ND1
|
A:HIS563
|
4.2
|
24.4
|
1.0
|
CG
|
A:HIS529
|
4.2
|
29.6
|
1.0
|
O
|
A:HOH942
|
4.4
|
32.1
|
1.0
|
CB
|
A:ASP674
|
4.5
|
34.0
|
1.0
|
NE2
|
A:HIS525
|
4.5
|
28.4
|
1.0
|
O
|
A:HOH929
|
4.6
|
20.4
|
1.0
|
CG2
|
A:VAL533
|
4.7
|
22.8
|
1.0
|
O
|
A:ASP674
|
4.7
|
31.4
|
1.0
|
O
|
A:HOH991
|
4.7
|
45.1
|
1.0
|
CA
|
A:ASP674
|
4.9
|
28.9
|
1.0
|
|
Zinc binding site 2 out
of 4 in 5sed
Go back to
Zinc Binding Sites List in 5sed
Zinc binding site 2 out
of 4 in the Crystal Structure of Human Phosphodiesterase 10 in Complex with 4-[6- Chloro-2-[(1-Methyl-4-Phenylimidazol-2-Yl)Methoxy]Quinazolin-4- Yl]Morpholine
 Mono view
 Stereo pair view
|
A full contact list of Zinc with other atoms in the Zn binding
site number 2 of Crystal Structure of Human Phosphodiesterase 10 in Complex with 4-[6- Chloro-2-[(1-Methyl-4-Phenylimidazol-2-Yl)Methoxy]Quinazolin-4- Yl]Morpholine within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:Zn801
b:31.1
occ:1.00
|
NE2
|
B:HIS563
|
2.0
|
25.9
|
1.0
|
O
|
B:HOH929
|
2.0
|
16.2
|
1.0
|
OD2
|
B:ASP564
|
2.0
|
23.9
|
1.0
|
OD1
|
B:ASP674
|
2.2
|
29.6
|
1.0
|
NE2
|
B:HIS529
|
2.2
|
27.1
|
1.0
|
O
|
B:HOH956
|
2.4
|
29.8
|
1.0
|
CD2
|
B:HIS563
|
3.0
|
27.3
|
1.0
|
CE1
|
B:HIS563
|
3.0
|
26.1
|
1.0
|
CG
|
B:ASP674
|
3.0
|
28.6
|
1.0
|
CG
|
B:ASP564
|
3.0
|
23.6
|
1.0
|
CD2
|
B:HIS529
|
3.2
|
27.2
|
1.0
|
OD2
|
B:ASP674
|
3.2
|
28.7
|
1.0
|
CE1
|
B:HIS529
|
3.3
|
26.8
|
1.0
|
OD1
|
B:ASP564
|
3.5
|
22.1
|
1.0
|
MG
|
B:MG802
|
3.9
|
21.4
|
1.0
|
ND1
|
B:HIS563
|
4.1
|
27.2
|
1.0
|
O
|
B:HOH982
|
4.1
|
18.9
|
1.0
|
CG
|
B:HIS563
|
4.1
|
25.4
|
1.0
|
O
|
B:HOH967
|
4.1
|
32.2
|
1.0
|
CD2
|
B:HIS525
|
4.2
|
27.2
|
1.0
|
CB
|
B:ASP564
|
4.3
|
22.6
|
1.0
|
CG
|
B:HIS529
|
4.3
|
25.6
|
1.0
|
ND1
|
B:HIS529
|
4.4
|
26.9
|
1.0
|
CB
|
B:ASP674
|
4.4
|
29.2
|
1.0
|
NE2
|
B:HIS525
|
4.4
|
28.9
|
1.0
|
O
|
B:HOH914
|
4.5
|
22.2
|
1.0
|
CG2
|
B:VAL533
|
4.8
|
25.0
|
1.0
|
O
|
B:ASP674
|
4.8
|
30.4
|
1.0
|
CA
|
B:ASP674
|
4.9
|
26.1
|
1.0
|
|
Zinc binding site 3 out
of 4 in 5sed
Go back to
Zinc Binding Sites List in 5sed
Zinc binding site 3 out
of 4 in the Crystal Structure of Human Phosphodiesterase 10 in Complex with 4-[6- Chloro-2-[(1-Methyl-4-Phenylimidazol-2-Yl)Methoxy]Quinazolin-4- Yl]Morpholine
 Mono view
 Stereo pair view
|
A full contact list of Zinc with other atoms in the Zn binding
site number 3 of Crystal Structure of Human Phosphodiesterase 10 in Complex with 4-[6- Chloro-2-[(1-Methyl-4-Phenylimidazol-2-Yl)Methoxy]Quinazolin-4- Yl]Morpholine within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
C:Zn801
b:33.4
occ:1.00
|
NE2
|
C:HIS563
|
2.0
|
31.1
|
1.0
|
O
|
C:HOH930
|
2.1
|
20.2
|
1.0
|
OD2
|
C:ASP564
|
2.1
|
25.9
|
1.0
|
NE2
|
C:HIS529
|
2.1
|
27.1
|
1.0
|
OD1
|
C:ASP674
|
2.2
|
28.4
|
1.0
|
O
|
C:HOH975
|
2.3
|
31.5
|
1.0
|
CD2
|
C:HIS563
|
2.9
|
29.0
|
1.0
|
CD2
|
C:HIS529
|
3.1
|
25.2
|
1.0
|
CE1
|
C:HIS563
|
3.1
|
30.3
|
1.0
|
CG
|
C:ASP674
|
3.1
|
26.7
|
1.0
|
CG
|
C:ASP564
|
3.1
|
27.0
|
1.0
|
CE1
|
C:HIS529
|
3.2
|
28.2
|
1.0
|
OD2
|
C:ASP674
|
3.4
|
27.9
|
1.0
|
OD1
|
C:ASP564
|
3.6
|
30.2
|
1.0
|
MG
|
C:MG802
|
3.8
|
23.4
|
1.0
|
CG
|
C:HIS563
|
4.1
|
27.1
|
1.0
|
CD2
|
C:HIS525
|
4.1
|
34.1
|
1.0
|
ND1
|
C:HIS563
|
4.2
|
26.4
|
1.0
|
CG
|
C:HIS529
|
4.3
|
26.4
|
1.0
|
ND1
|
C:HIS529
|
4.3
|
27.1
|
1.0
|
CB
|
C:ASP564
|
4.3
|
25.6
|
1.0
|
O
|
C:HOH939
|
4.4
|
25.6
|
1.0
|
O
|
C:HOH912
|
4.4
|
22.4
|
1.0
|
NE2
|
C:HIS525
|
4.4
|
30.5
|
1.0
|
O
|
C:HOH988
|
4.5
|
26.7
|
1.0
|
CB
|
C:ASP674
|
4.5
|
28.4
|
1.0
|
CG2
|
C:VAL533
|
4.8
|
26.1
|
1.0
|
CA
|
C:ASP674
|
4.8
|
28.1
|
1.0
|
O
|
C:ASP674
|
4.9
|
31.6
|
1.0
|
|
Zinc binding site 4 out
of 4 in 5sed
Go back to
Zinc Binding Sites List in 5sed
Zinc binding site 4 out
of 4 in the Crystal Structure of Human Phosphodiesterase 10 in Complex with 4-[6- Chloro-2-[(1-Methyl-4-Phenylimidazol-2-Yl)Methoxy]Quinazolin-4- Yl]Morpholine
 Mono view
 Stereo pair view
|
A full contact list of Zinc with other atoms in the Zn binding
site number 4 of Crystal Structure of Human Phosphodiesterase 10 in Complex with 4-[6- Chloro-2-[(1-Methyl-4-Phenylimidazol-2-Yl)Methoxy]Quinazolin-4- Yl]Morpholine within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
D:Zn801
b:44.5
occ:1.00
|
OD2
|
D:ASP564
|
2.0
|
55.3
|
1.0
|
NE2
|
D:HIS563
|
2.1
|
34.2
|
1.0
|
NE2
|
D:HIS529
|
2.2
|
44.5
|
1.0
|
O
|
D:HOH909
|
2.2
|
26.9
|
1.0
|
OD1
|
D:ASP674
|
2.2
|
40.0
|
1.0
|
O
|
D:HOH912
|
2.4
|
40.8
|
1.0
|
CD2
|
D:HIS563
|
2.9
|
34.4
|
1.0
|
CG
|
D:ASP564
|
3.1
|
46.1
|
1.0
|
CD2
|
D:HIS529
|
3.1
|
43.6
|
1.0
|
CG
|
D:ASP674
|
3.1
|
37.8
|
1.0
|
CE1
|
D:HIS563
|
3.2
|
36.3
|
1.0
|
CE1
|
D:HIS529
|
3.2
|
42.5
|
1.0
|
OD2
|
D:ASP674
|
3.3
|
40.5
|
1.0
|
OD1
|
D:ASP564
|
3.7
|
45.4
|
1.0
|
MG
|
D:MG802
|
3.9
|
38.8
|
1.0
|
O
|
D:HOH928
|
4.1
|
39.3
|
1.0
|
CD2
|
D:HIS525
|
4.1
|
46.1
|
1.0
|
CG
|
D:HIS563
|
4.1
|
35.7
|
1.0
|
O
|
D:HOH922
|
4.2
|
33.0
|
1.0
|
CB
|
D:ASP564
|
4.2
|
41.5
|
1.0
|
ND1
|
D:HIS563
|
4.2
|
35.1
|
1.0
|
CG
|
D:HIS529
|
4.3
|
43.5
|
1.0
|
ND1
|
D:HIS529
|
4.3
|
43.7
|
1.0
|
NE2
|
D:HIS525
|
4.5
|
44.4
|
1.0
|
CB
|
D:ASP674
|
4.5
|
40.7
|
1.0
|
O
|
D:HOH902
|
4.6
|
32.4
|
1.0
|
CG2
|
D:VAL533
|
4.7
|
45.2
|
1.0
|
O
|
D:ASP674
|
4.8
|
45.8
|
1.0
|
CA
|
D:ASP674
|
4.9
|
42.0
|
1.0
|
|
Reference:
A.Tosstorff,
M.G.Rudolph,
J.C.Cole,
M.Reutlinger,
C.Kramer,
H.Schaffhauser,
A.Nilly,
A.Flohr,
B.Kuhn.
A High Quality, Industrial Data Set For Binding Affinity Prediction: Performance Comparison in Different Early Drug Discovery Scenarios. J.Comput.Aided Mol.Des. V. 36 753 2022.
ISSN: ESSN 1573-4951
PubMed: 36153472
DOI: 10.1007/S10822-022-00478-X
Page generated: Mon Oct 28 04:38:43 2024
|